Flucytosine in urinary candida infections.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000908:Antibodies, Fungal / Q000032:analysis; D000935:Antifungal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001853:Bone Marrow / Q000187:drug effects; D002176:Candida albicans; D002177:Candidiasis / Q000188:drug therapy*; D003596:Cytosine / Q000627:therapeutic use*; D005260:Female; D005437:Flucytosine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008099:Liver / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000908:Antibodies, Fungal; D000935:Antifungal Agents; D003596:Cytosine; D005437:Flucytosine